Well....not a good day for ICGN, to say the least.
But, the lead compound, ICA-105665 is still in place in partnership with Pfizer.
Pfizer appears to have an average acquisition price of $1.80 +/- on their 8 millions shares held?
Am I correct? Would certainly seem like an opportunity for them and us to "average down". Thoughts?